agilon health (AGL) Scheduled to Post Earnings on Tuesday

agilon health (NYSE:AGL) is set to release its earnings data after the market closes on Tuesday, May 7th. Analysts expect agilon health to post earnings of ($0.01) per share for the quarter. agilon health has set its FY 2024 guidance at EPS.Investors interested in participating in the company’s conference call can do so using this link.

agilon health (NYSE:AGL) last issued its earnings results on Tuesday, February 27th. The company reported ($0.41) EPS for the quarter, missing analysts’ consensus estimates of ($0.28) by ($0.13). agilon health had a negative return on equity of 21.74% and a negative net margin of 5.76%. The business had revenue of $1.06 billion during the quarter, compared to analysts’ expectations of $1.02 billion. During the same quarter in the previous year, the business earned ($0.14) EPS. agilon health’s revenue for the quarter was up 71.8% compared to the same quarter last year. On average, analysts expect agilon health to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

agilon health Stock Performance

NYSE AGL opened at $4.83 on Monday. The company has a 50-day simple moving average of $5.41 and a two-hundred day simple moving average of $8.89. agilon health has a 12-month low of $4.41 and a 12-month high of $26.75. The firm has a market cap of $1.99 billion, a price-to-earnings ratio of -7.43 and a beta of 0.52. The company has a quick ratio of 1.51, a current ratio of 1.51 and a debt-to-equity ratio of 0.05.

Wall Street Analyst Weigh In

Several equities research analysts recently weighed in on the company. Barclays assumed coverage on agilon health in a report on Wednesday, March 6th. They set an “underweight” rating and a $5.00 target price for the company. Evercore ISI dropped their price objective on agilon health from $7.00 to $6.00 and set an “in-line” rating for the company in a research note on Wednesday, February 28th. SVB Leerink lowered agilon health from an “outperform” rating to a “market perform” rating in a research note on Monday, January 8th. TD Cowen lowered agilon health from an “outperform” rating to a “market perform” rating and dropped their price objective for the company from $12.00 to $6.50 in a research note on Monday, February 26th. Finally, Royal Bank of Canada dropped their price objective on agilon health from $11.00 to $8.00 and set an “outperform” rating for the company in a research note on Wednesday, February 28th. One investment analyst has rated the stock with a sell rating, twelve have issued a hold rating and four have issued a buy rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Hold” and a consensus target price of $9.32.

About agilon health

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.